Brigimadlin: Mechanism of Action

Brigimadlin MOA:Targeting MDM2/p53 Pathway for Dedifferentiated Liposarcoma

🎯 check Brigimadlin product page

Brigimadlin is a potent MDM2 antagonist. It affects p53 signaling by upregulating p53, inhibiting tumor cell viability.

Primary Applications and Mechanism of Action